Thyroid function and cancer risk: A prospective population study

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 2, 2009, Pages 570-574

  Hellevik, Alf Inge ^a   Åsvold, Bjarn Olav ^a,e   Bjøro, Trine ^c   Romundstad, Pål R ^a   Nilsen, Tom Ivar L ^b   Vatten, Lars J ^a,d  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; THYROID FUNCTION;

ADULT; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; THYROID FUNCTION TESTS; THYROTROPIN;

EID: 60549085566     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0911     Document Type: Article

References (21)

1. Hercbergs A. The thyroid gland as an intrinsic biologic response-modifier in advanced neoplasia-a novel paradigm. In Vivo 1996;10:245-7.
2. Davis FB, Tang HY, Shih A, et al. Acting via a cell surface receptor, thyroid hormone isa growth factor for glioma cells. Cancer Res2006;66:7270-5.
3. Nelson M, Hercbergs A, Rybicki L, Strome M. Association between development of hypothyroidism and improved survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2006;132:1041-6.
4. Cristofanilli M, Yamamura Y, Kau SW, et al. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 2005;103:1122-8.
5. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999;353:2111-5.
6. Ron E, Doody MM, Becker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998;280:347-55.
7. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990;50:2283-9.
8. Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthy-roidism. Cancer 2007;109:1972-9.
9. Smyth PP, Shering SG, Kilbane MT, et al. Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 1998;83:2711-6.
10. Kumar MS, Chiang T, Deodhar SD. Enhancing effect of thyroxine on tumor growth and metastases in syngeneic mouse tumor systems. Cancer Res1979;39:3515-8.
11. Mishkin SY, Pollack R, Yalovsky MA, Morris HP, Mishkin S. Inhibition of local and metastatic hepatoma growth and prolongation of survival after induction of hypothyroidism. Cancer Res 1981;41:3040-5.
12. Vonderhaar BK, Greco AE. Effect of thyroid status on development of spontaneous mammary tumors in primiparous C3H mice. Cancer Res1982;42:4553-61.
13. Shoemaker JP, Bradley RL, Hoffman RV. Increased survival and inhibition of mammary tumorsin hypothyroid mice. J Surg Res1976;21:151-4.
14. Holmen J, Midthjell K, Kruger O, et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 2003;13:19-32. http://www.ntnu.no/eksternweb/multimedia/archive/ 00037/metodeartikkel-37894a.pdf (accessed December 26, 2008).
15. Bjoro T, Holmen J, Kruger O, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000;143:639-47.
16. Kapelrud H, Frey H, Theodorsen L. Excretion of iodine in the urine. A study from 6 different Norwegian districts in 1985. Tidsskr Nor Laegeforen 1987;107:1320-1, 1317.
17. Asvold BO, Bjoro T, Nilsen TI, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med 2007;167:1428-32.
18. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001;358:861-5.
19. De Groot LJ. Dangerousdogmasin medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999;84:151-64.
20. Humes HD, Cieslinski DA, Johnson LB, Sanchez IO. Triiodothyro-nine enhancesrenal tubule cell replication by stimulating EGF receptor gene expression. Am J Physiol 1992;262:F540-5.
21. Davis FB, Mousa SA, O'Connor L, et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 2004;94:1500-6.